Skip to content
    Casdin Capital logo

    Casdin Capital

    New York, New York, United StatesFounded 2012
    casdincapital.comLinkedIn
    HealthcareBiotech & Life Sciences

    Casdin Capital focuses on investing in disruptive life science companies, particularly those in biotechnology, genomics, and healthcare tools and diagnostics. Their strategy involves a long-term, multi-stage approach to support transformative innovation across the sector.

    Find people at Casdin Capital on Goldilocks AI

    Portfolio

    17

    Fund Size

    $1.6B

    Top Stage

    Series B

    Last 12 Mo

    1

    Team

    JB

    Jordan Bettman

    Partner

    WG

    Weston Gaddy

    Partner

    SR

    Shaun Rodriguez, PhD

    Director of Life Science Research

    NB

    Noah Burhance

    Research Associate

    YC

    Yi Chi Song

    Research Associate

    EM

    Eileen Maysek

    Research Analyst

    EC

    Eli Casdin

    Chief Investment Officer

    BW

    Brad Weisgerber

    Head Trader

    Stage Distribution

    Portfolio

    17 investments
    CompanyRoundAmountDate
    ApellaSeries B$80MJan 2026
    Thyme CareSeries B$60MAug 2023
    Flare Therapeutics Inc.Series B$123MMar 2023
    Volta LabsSeries A$20MMar 2022
    Creyon BioSeed$40MMar 2022
    MeiogenixSeries A$13MDec 2021
    Mnemo TherapeuticsSeries A$90MJun 2021
    Vedere Bio II, Inc.Series A$77MMay 2021
    Affinia TherapeuticsSeries B$110MMay 2021
    C2i GenomicsSeries B$100MApr 2021
    AbSciSeries D$125MMar 2021
    Amunix Pharmaceuticals, Inc.Series B$117MMar 2021
    Notch Therapeutics, Inc.Series A$85MFeb 2021
    A2 BiotherapeuticsSeries B$71.5MOct 2020
    Tenaya Therapeutics, Inc.Series B$92MOct 2019
    Lyra HealthSeries D$110M—
    EarliSeries A$40M—

    Top Co-Investors

    Alexandria Venture Investments3 shared
    Perceptive Advisors3 shared
    Samsara BioCapital3 shared
    Redmile Group3 shared
    Nextech Invest2 shared
    Sofinnova Partners2 shared
    Khosla Ventures2 shared
    Atlas Venture2 shared
    The Column Group2 shared
    Avidity Partners2 shared
    GV (Google Ventures)2 shared
    ArrowMark Partners2 shared
    Addition1 shared
    Adams Street1 shared
    Glynn Capital1 shared
    Greylock Partners1 shared
    IVP (Institutional Venture Partners)1 shared
    Meritech Capital1 shared
    Tenaya Capital1 shared
    Eventide Asset Management1 shared

    Last updated: 1 March 2026